Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 15, 2014

Primary Completion Date

January 24, 2023

Study Completion Date

January 24, 2023

Conditions

Stage IV Lung Adenocarcinoma

Interventions

DRUG

Certolizumab

DRUG

cisplatin

DRUG

pemetrexed

Trial Locations (6)

Memorial Sloan Kettering Cancer Center, New York

Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center, Sleepy Hollow

Memorial Sloan Kettering West Harrison, Harrison

Memorial Sloan Kettering Cancer Center @ Suffolk, Commack

Memorial Sloan Kettering at Basking Ridge, Basking Ridge

Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02120807 - Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas | Biotech Hunter | Biotech Hunter